Next Science Limited is a medical technology company that focuses on eradicating health issues caused by biofilms. Their products, developed using their Xbio Technology platform, include antimicrobial gels and solutions designed to reduce surgical site and post-surgical infections. They have partnerships with respected institutions such as the Mayo Clinic and the University of Florida Department of Otolaryngology. Founded in 2012 and headquartered in Australia, Next Science Limited also has operations in the United States.